Back to search

Democritus University of Thrace (DUTH)

Μελέτη της έκφρασης της πρωτεϊνης S100 και συσχετισμός της με άλλα μοριακά μονοπάτια που συμμετέχουν στην καρκινογένεση, σε ασθενείς με μη -μικροκυτταρικό καρκίνο του πνεύμονα

Abstract

dc:description

Regarding S100A2 and its role in NSCLC there are conflicting published results. Feng et al showed that S100A2 expression was downregulated and on the contrary Heighway et al showed that S100A2 strongly expressed. Wang et al showed that S100A2 protein was also strongly expressed in NSCLC. The aim of this study is to analyse the nuclear, cytoplasmic expression and intensity pattern of S100A2 protein as well as to correlate this with other clinicopathologic characteristics and molecules (p53, Caspase 3, Ki-67, ERCC1, RRM1) involved in carcinogenesis, in NSCLC patients. We also analyzed their prognostic role on overall survival and disease free interval. Microarray data for 74 paraffin-embedded specimens from patients with NSCLC were immunostained for S100A2 and p53 proteins. Immunohistochemical staining patterns of S100A2 in the NSCLC tissue samples examined were either nuclear (nS100A2), cytoplasmic (cS100A2), or both. A significant association between nS100A2 positivity and better disease-free interval was observed (p=0.047). Patients without lymphatic infiltration and an earlier disease stage had significantly better overall survival and disease-free interval. The S100A2 expression pattern in operable NSCLC varies widely, and this differential expression (nuclear, cytoplasmic or both) seems to correlate with prognosis. Intensity of expression was highest in the early and advanced stages, and equally distributed in the middle stages. This is indicative for at least a dual role of this protein in carcinogenesis.ERCC1 (Excision repair cross-complementation group 1) is one crucial enzyme in the nucleotide repair process with excision. RRM1 (Ribonucleotide reductase subunit M1) has been involved in the synthesis and DNA repair and in gemcitabine metabolism. ERCC1 and RRM1 mRNAs were counted with the ΔΔCT method using b- actin as the reference gene. There were no statistical significant correlations between these genes expression, clinicopathologic parameters and overall survival or disease free interval.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Hountis, Panagiotis
  • Χουντής, Παναγιώτης

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/39098

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Hountis, Panagiotis; Χουντής, Παναγιώτης. Μελέτη της έκφρασης της πρωτεϊνης S100 και συσχετισμός της με άλλα μοριακά μονοπάτια που συμμετέχουν στην καρκινογένεση, σε ασθενείς με μη -μικροκυτταρικό καρκίνο του πνεύμονα. Democritus University of Thrace (DUTH), 2013. http://hdl.handle.net/10442/hedi/39098